GOAL-AI

GOAL-AI

Es posible que algunos contenidos no estén disponibles en español.

Purpose of this Study

In this study, people will answer questions and do simple physical tests three times over six months. They will be randomly placed into one of two groups: one gets coping skills training with a nurse by phone, and the other gets regular care. Everyone will also get a short health check during cancer visits to look for problems like memory loss or falling.

Who Can Participate?

Eligibility

This study is for women aged 65 or older who had breast cancer that did not spread. They must have started taking a medicine called an aromatase inhibitor within the past year.

Age Range

65-110

Sex/Genders

Female (cisgender)
Looking for Healthy Participants
No

What is Involved?

Description

This study wants to help older women with breast cancer feel better while taking a medicine called an aromatase inhibitor. This medicine helps treat cancer but can cause side effects that make it hard to keep using.

Locations

Duke University Hospital
Duke Regional Hospital
Duke Raleigh Hospital
Other

Visit Timing

Weekdays

Compensation

Yes

Spanish Materials Available

No

Study Details

Full Title

Geriatric Oncology Assessment to Link with Support for Older Women Taking Adjuvant Aromatase Inhibitor Therapy

Principal Investigator

Rebecca
Shelby

Protocol Number

PRO00118528

Enrollment Status

Pending Open to Enrollment